These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21134049)

  • 41. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe.
    Ali A; Martin JM
    J Drugs Dermatol; 2010 Jan; 9(1):62-4. PubMed ID: 20120427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis.
    Lew BL; Shin MK; Sim WY
    J Am Acad Dermatol; 2009 Jan; 60(1):85-93. PubMed ID: 18992964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Morohashi M; Takeuchi S; Sato Y
    Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a role for sulfasalazine in the treatment of alopecia areata?
    Bakar O; Gurbuz O
    J Am Acad Dermatol; 2007 Oct; 57(4):703-6. PubMed ID: 17610992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of the therapeutic effect of DNBC-induced contact dermatitis in alopecia areata].
    Broniarczyk-Dyła G; Omulecki A
    Przegl Dermatol; 1983; 70(5-6):557-61. PubMed ID: 6366925
    [No Abstract]   [Full Text] [Related]  

  • 47. Predicting migraine responsiveness to botulinum toxin type A injections.
    Kim CC; Bogart MM; Wee SA; Burstein R; Arndt KA; Dover JS
    Arch Dermatol; 2010 Feb; 146(2):159-63. PubMed ID: 20157026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata.
    Waiz M; Saleh AZ; Hayani R; Jubory SO
    J Cosmet Laser Ther; 2006 Apr; 8(1):27-30. PubMed ID: 16581682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathologic features of alopecia areata: a new look.
    Whiting DA
    Arch Dermatol; 2003 Dec; 139(12):1555-9. PubMed ID: 14676070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.
    Kubeyinje EP
    East Afr Med J; 1994 Oct; 71(10):674-5. PubMed ID: 7821250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral treatment for alopecia areata.
    Torchia D; Schachner LA
    Pediatr Dermatol; 2010; 27(4):415-6. PubMed ID: 20653874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of patients with alopecia areata and total alopecia by intracutaneous injections of hydrocortisone].
    Kononenko OG
    Vestn Dermatol Venerol; 1966 May; 40(5):59-62. PubMed ID: 5989830
    [No Abstract]   [Full Text] [Related]  

  • 55. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
    Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
    J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice?
    Civaş E; Aksoy B; Aksoy HM; Eski M; Yucel K
    J Dermatol; 2010 Sep; 37(9):823-6. PubMed ID: 20883369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Alopecia areata: successful half-side treatment with DNCB].
    Happle R; Echternacht K
    Z Hautkr; 1977 Nov; 52(22):1129-34. PubMed ID: 595747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical experience in the treatment of alopecia areata by local injections of Circulatin].
    Hironaka T; Hirata K
    Horumon To Rinsho; 1966 Feb; 14(2):181-3. PubMed ID: 6006545
    [No Abstract]   [Full Text] [Related]  

  • 60. Keloid scars and treatment with Botulinum Toxin Type A: the Belfast experience.
    Robinson AJ; Khadim MF; Khan K
    J Plast Reconstr Aesthet Surg; 2013 Mar; 66(3):439-40. PubMed ID: 23092904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.